Register
Formulation Development

Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
More...
Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...




Polymorph Screens


Polymorphs are examples of single compounds which, although chemically identical, exist in two or more different crystalline structures. The presence of single or multiple polymorphs can present both drug substance and drug product issues. Differences in physical and chemical properties of drug substance can impact bioavailability, dissolution rate, oral absorption, pharmacokinetics, ease of manufacturing and dosage form stability.

Strategy: Conduct a polymorph screen of a drug substance using a selection of possible solvents that have come into contact with or may come into contact with the drug substance during synthesis, purification, process, cleaning, and/or salt formation.

Method: A typical polymorph screen consists of a selection of solvents to evaluate for possible chemical and physical interactions. The procedure consists of dissolving the drug substance individually into the chosen solvents or a slurry creation at room temperature and/or elevated temperatures (example: 50°C). The available material is then isolated from the solvent or slurry in various procedures; precipitation, evaporation (rapid or slow), cooling, etc. All material isolated is then evaluated in comparison to the initial unaltered material (i.e. a baseline) by use of XRPD, thermal evaluation by Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA), polarized microscope (for morphology and birefringence observations) and FT-IR. Additional tests can be conducted if deemed necessary which might include the following; solubility and pH properties, vapor sorption and/or particle size evaluation.

Result: The identification of polymorphs generally differ in their morphology, chemical and physical stability, melting point, density, solubility, heat of fusion and dissolution rate to list a few. DSC evaluation is used as a tool to verify differences in onset temperatures, melting temperatures and heat of fusion of the isolated materials. This evaluation is to determine the most suitable form, or the thermodynamically most stable form.






Home | Services | Corporate | Publications | Equipment List | Resources | News | Career | Contact


Drug Development Services | Pharmaceutical Pre-Formulation Development | Pharmaceutical Formulation Development
Drug Development Analytical Method | Xcelodose Drug Manufacturing | Drug Delivery Expert Consulting | BOOKMARK US

Copyright © 2010 Xcelience All rights reserved.
Website Designed by GI & Hi-Tech - Tampa, FL